Recurrent Esophageal Carcinoma Recruiting Phase 2 Trials for Dabrafenib (DB08912)

Also known as: Oesophageal carcinoma recurrent / Recurrent Oesophageal Carcinoma / Oesophageal carcinoma site unspecified recurrent / Esophageal carcinoma site unspecified recurrent / Esophageal carcinoma recurrent